NowPatient Tirzepatide Review: Cost, Brand-Only Access & Honest Verdict (2026)

NowPatient is a US-UK telehealth platform offering only FDA-approved brand-name GLP-1s — Mounjaro, Wegovy (injection and oral tablet), and Saxenda — with no compounded alternative at all, a genuinely different model from most providers here. Every fact here comes from the company's own published program.

What NowPatient is

NowPatient is a US-UK telehealth platform, offering brand-name GLP-1 weight management access. It's one of the few platforms offering Wegovy in both injection and oral pill form, alongside Mounjaro and Saxenda. A live video visit is required before any prescription.

What NowPatient costs

The telehealth consultation is free — you only pay for the medication itself — but pricing tracks the full brand list price, roughly $1,000-$1,350/month, with a promotional Mounjaro rate around $1,069/month. This is significantly more expensive than any compounded option here.

The brand-vs-compounded question

NowPatient offers only FDA-approved brand-name medications — no compounded semaglutide or tirzepatide — a genuine differentiator from most providers reviewed on this site. This means every drug dispensed is the exact molecule and dose tested in the pivotal trials, at the cost of the full brand list price. See our best place to get Zepbound online roundup for other brand-focused options.

How the care model holds up

NowPatient's real strengths is a free telehealth consultation, exclusively FDA-approved brand-name medications with no compounded ambiguity, Wegovy available in both injection and oral pill form — uncommon among competitors — and a required live video visit for real clinical oversight. The trade-offs: pricing tracks the full brand list price (roughly $1,000-$1,350/month), significantly above any compounded alternative, state availability is determined only during intake, and it doesn't offer Foundayo (orforglipron). As with any GLP-1 program, and especially a brand-only one at this price point, compare the full cost against insurance coverage or manufacturer savings programs before committing; tirzepatide carries labeled warnings for acute pancreatitis, gallbladder disease, and a boxed thyroid C-cell tumor warning — see our guides on Zepbound side effects, the gallbladder risk, and the thyroid cancer warning.

Does the drug work? (Separate from the provider)

Judge the provider on price, oversight and disclosure; judge the molecule on its trials. Tirzepatide's are strong — roughly 15–21% of body weight over 72 weeks in SURMOUNT-1¹, and better than semaglutide head-to-head² — but they were run on the brand drug at FDA-approved doses. Our tirzepatide evidence guide has the full picture.

The honest verdict

NowPatient's free consultation and exclusively brand-name, FDA-approved medication lineup are genuine strengths for patients who want zero compounded-drug ambiguity, but the full list-price cost puts it well above every compounded competitor here. For a compounded alternative at a fraction of the price, compare it against CoreAge Rx or NewSelf; for the FDA-approved brand pathway priced against insurance, see our best place to get Zepbound online roundup. For an LGBTQ+-friendly platform on the same brand-only model, see PrideRx. See our best tirzepatide providers ranking for the full field.